Bluestone Trials

Symptoms Related to Chemotherapy Study

Seeking patients receiving chemotherapy for breast, gastrointestinal, gynecologic, or lung cancer.
Status: Completed.

The Bluestone Center for Clinical Research and the NYU Langone Medical Center, funded by the National Cancer Institute are seeking volunteers to take part in a clinical research study. The purpose of this study is to better understand how symptoms (i.e. fatigue, nausea, pain, sleep disturbance, and depression) change during chemotherapy and if some cancer patients have an inherited tendency to experience more severe symptoms than other cancer patients.

You are being asked to participate in this study because you have received chemotherapy within the past 4 weeks and have at least 2 more cycles of chemotherapy to complete. Prior clinical research in oncology patients has suggested that symptom clusters have negative effects on patient outcomes and may require different treatments than a single symptom within a cluster.

Study Details 
Participants 18 and older will complete a set of questionnaires at 6 different time points: before, during and after 2 cycles of chemotherapy. Questionnaires are related to participant symptoms, quality of life, and stressful life events during and between chemotherapy sessions. Patients must have a diagnosis of breast, gastrointestinal, gynecologic, or lung cancer, be fluent in English, and willing to give a blood sample for genomic analyses. Participation will involve 2 visits during administration of chemotherapy. Study participants will not be required to come in for any additional visits. Confidentiality will be maintained for all participants.